Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy

BACKGROUND: More than one-third of the estimated 2 million prostate cancer survivors in the United States receive androgen deprivation therapy (ADT). This population of mostly older men is medically vulnerable to a variety of treatment-associated adverse effects. MEASUREMENTS AND RESULTS: Androgen-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Saylor, Philip J., Keating, Nancy L., Smith, Matthew R.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Clinical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763167/
https://www.ncbi.nlm.nih.gov/pubmed/19838837
http://dx.doi.org/10.1007/s11606-009-0968-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763167/
https://www.ncbi.nlm.nih.gov/pubmed/19838837
http://dx.doi.org/10.1007/s11606-009-0968-y

Ejemplares similares